Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=109"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=109

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03964415-8c897a4e",
        "title": "Group 1: Ad26.Mos4.HIV + Clade C and Mosaic gp140 vs Group 2: Placebo: Number of Participants With Adverse Events of Special Interest (AESIs)",
        "summary": "4 of 1942 against 2 of 1945; risk difference 0.1 points, 95% interval -0.2 to 0.4; NCT03964415, A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals",
        "record": "/library/comparisons/NCT03964415-8c897a4e",
        "nct_id": "NCT03964415",
        "kind": "outcome",
        "participants": 3887,
        "risk_difference": {
          "value": 0.0010314545998480352,
          "lower": -0.0019595190463227294,
          "upper": 0.004341195213503152
        },
        "group_1": "4 of 1,942",
        "group_2": "2 of 1,945",
        "difference": "0.1 points",
        "interval": "-0.2 to 0.4",
        "trial_title": "A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals"
      },
      {
        "id": "NCT03964415-deaths",
        "title": "Group 1: Ad26.Mos4.HIV + Clade C and Mosaic gp140 vs Group 2: Placebo: deaths from any cause",
        "summary": "4 of 1942 against 6 of 1945; risk difference -0.1 points, 95% interval -0.5 to 0.3; NCT03964415, A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals",
        "record": "/library/comparisons/NCT03964415-deaths",
        "nct_id": "NCT03964415",
        "kind": "deaths",
        "participants": 3887,
        "risk_difference": {
          "value": -0.0010251006700748443,
          "lower": -0.004866367928916284,
          "upper": 0.002606338670344156
        },
        "group_1": "4 of 1,942",
        "group_2": "6 of 1,945",
        "difference": "-0.1 points",
        "interval": "-0.5 to 0.3",
        "trial_title": "A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=110",
  "request_id": "CXV_lCOBuUCdNxOU"
}